VBI Vaccines
VBIV
0,05976 €
Share price
0.00%
Change (1 day)
-92.95%
Change (1 year)
Categories
Revenue for VBI Vaccines (VBIV)
Revenue in 2024 (TTM): €8.81 Million
According to VBI Vaccines
's latest financial reports the company's current revenue (TTM 
) is €8.61 Million. In 2023 the company made a revenue of €7.85 Million an increase over the revenue in the year 2022 that were of €1 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for VBI Vaccines from 1998 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | €8.81 M | 12.24% |
| 2023 | €7.85 M | 678.6% |
| 2022 | €1 M | 81.04% |
| 2021 | €0.55 M | -35.41% |
| 2020 | €0.86 M | -56.49% |
| 2019 | €1.98 M | -32.4% |
| 2018 | €2.93 M | 306.8% |
| 2017 | €0.72 M | 38.38% |
| 2016 | €0.52 M | 506.01% |
| 2015 | €0.08 M | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A | |
| 2000 | €0.07 M | -65.14% |
| 1999 | €0.2 M | 22.14% |
| 1998 | €0.16 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | €0.2 M | -97.60% | 🇺🇸 USA |
 | €0.76 B | 8,800.22% | 🇺🇸 USA |
 | €9.98 M | 15.91% | 🇺🇸 USA |